Gujarat Tops Among States in Project Investment Approved by Financial Institutions in 2007-08
Gujarat Tops Among States in Project Investment Approved by Financial Institutions in 2007-08
Gujarat Tops Among States in Project Investment Approved by Financial Institutions in 2007-08
1
Global Pharmaceutical Industry
Global pharmaceutical industry has toched US$ 727 billion in 2008 registering a growth of 5-6%
4.50%
of lifestyle-related diseases in the global population 8.60%
9.30%
North America remains the largest pharmaceutical market with
47.70%
29.90%
Global pharmaceutical market is witnessing increased
North Am erica (USA & Canada) Europe
Japan Africa, Asia (excluding Japan) & Australia
opportunities in the area of Latin Am erica IMS MIDAS, MAT December 2006
among others
Source: Extract from RNCOS World Pharmaceutical market 2007, IMS 2008 Global Pharmaceutical Market forecast
2
Indian Pharmaceutical Industry
Indian pharmaceutical industry ranks 4th in terms of volume and 15th in terms of value
In value-terms, Indian pharmaceutical industry is over US$8 billion Fig 2: Indian pharmaceuticals growth trend
14 Estimate
The industry holds 8% share in global volume sales and 1% share 12
CAGR
4
Indian pharmaceutical companies meet almost 70% of country’s
2
0
demand for bulk drugs 2001-02 2006-07 2011-12
Paris Negma
Wockhardt Ltd.
Laboratories
Indian Pharmaceutical Industry has grown at a CAGR of 13% from 2002-2007 and
is expected to grow at a CAGR of 16% over 2007-2011
Source: KPMG Pharma summit 2007, IBEF Pharma report 3
Gujarat: Pharmaceuticals- The centre of Gravity
Enablers
Regulatory
• Established chemical industry • Product Patent Regime
• Backward linkages • 310 World Health Organisation (WHO)
• Well-developed medical equipment industry compliant manufacturing units
• Well-developed IT capabilities • cGMP compliance of International standards
• Well-developed pharma machinery industry and • Government supported incentives and subsidies
pharma packaging
• Large number of CROs
• Academic and research institutes
Gujarat - The Pharmaceutical Hub
103 42% 40% 22% 55,000
years of of India’s pharma of India’s CRAMS of India’s pharma people employed in the
excellence sector turnover companies exports sector are in Gujarat
USD billion
8
5
6 CAGR 87.7%
4
4
3
2
2
1 0
India Gujarat
0
2002-03 2003-04 2004-05 2005-06 2006-07 total 2002-03 2006-07
Gujarat, an established manufacturing base for bulk drugs and formulations with its
inherent competitive advantages is poised to capture emerging global opportunities to
become a Global Pharmaceuticals Hub.
5
Gujarat - Key Statistics
All manufacturing units are compliant with Schedule M
310 license holders with WHO GMP certification
42+ units with international certification
100+ New Drug Applications (NDA) filed by various companies
109+ pharmacy colleges in Gujarat
Gujarat – export hub with exports to 200+ countries
Gujarat – R & D hub with presence of world class centers of companies like
Sun, Torrent, Intas, Zydus
160 Gujarat Sales Break up as per MAT June ‘08 Type II DMF Filings from Gujarat
140 135
120
USD million
100 90
80
60
40 32
23
20
0
Vadodara Surat Ahmedabad Rest
6
Gujarat – Key Features
Manufacturer of maximum number of dosages in the country
Only manufacturer in the country of ranitidine hydrochloride, with long shelf life. It is exported to US
and Europe
Safe from the menace of spurious drugs and hence it has better acceptance among medical fraternity
2,000
29
USD million
1056%
1,500 40%
60%
1,000 24%
500
178 93
-
Formulation Bulk Drugs
2003-04
2008-09